T-cells Expressing Anti-CD19 CAR in Pediatric and Young Adults With B-cell Malignancies

NCT02772198 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

300

Enrollment

OTHER_GOV

Sponsor class

Conditions

Acute Lymphoblastic Leukemia, B-precursor
Non-Hodgkin Lymphoma, B-cell

Interventions

BIOLOGICAL: CD19 CAR T cells

Sponsor

Sheba Medical Center